FDA Import Refusal 799-0117903-7/21/1 — Bgp Pharma Ulc

Bgp Pharma Ulc — FEI 3012204655

The FDA refused shipment 799-0117903-7/21/1 from Bgp Pharma Ulc (Canada) on Mar 20, 2024. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.